v3.25.2
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Restrictions on Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
June 30,
2025		June 30,
2024
Cash and cash equivalents$350 $183 
Restricted cash20 28 
Cash, cash equivalents and restricted cash$370 $211 
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
June 30,
2025		June 30,
2024
Cash and cash equivalents$350 $183 
Restricted cash20 28 
Cash, cash equivalents and restricted cash$370 $211 
Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share Shares used in computing basic and diluted earnings per share are as follows: 
Three Months Ended
June 30,		Nine Months Ended
June 30,
 2025202420252024
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic214,813 210,679 214,896 210,090 
Incremental shares issuable for stock options, common stock awards, and Equity Units (a)(b)— — 746 5,128 
UGI Corporation Senior Notes (c)— — 2,781 — 
Weighted-average common shares outstanding — diluted214,813 210,679 218,423 215,218 
(a)For the three months ended June 30, 2025 and 2024, 5,853 and 3,823 shares, respectively, have been excluded from the computation of diluted earnings per share as such incremental shares would be antidilutive due to the net losses for the periods. For the nine months ended June 30, 2025 and 2024, there were 5,212 and 8,487 shares, respectively, associated with outstanding stock option awards that were not included in the computation of diluted earnings per share above because their effect was antidilutive.
(b)The Equity Units were settled in June 2024. See “Equity Units” below for additional information.
(c)See Note 8 for additional information on the UGI Corporation Senior Notes.